Retroviral-mediated gene therapy for the differentiation of primary cells into a mineralizing osteoblastic phenotype

Methods in Molecular Biology

Volumn 434, Issue , 2008, Pages 333-354

  Phillips, Jennifer E ^a   García, Andrés J ^b  

^a Emory University

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Bone; Bone regeneration; Cellular therapy; Fibroblasts; Gene therapy; Osteoblasts; Regenerative medicine; Runx2 Cbfa1; Skin; Tissue engineering; Transcription factor

Indexed keywords

ANIMAL; ARTICLE; BIOASSAY; BONE DEVELOPMENT; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CELL SEPARATION; CYTOLOGY; DERMIS; FIBROBLAST; GENE THERAPY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; MALE; METHODOLOGY; OSTEOBLAST; PHENOTYPE; PROSTHESES AND ORTHOSES; RAT; RETROVIRUS; WISTAR RAT;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; DERMIS; ENDPOINT DETERMINATION; FIBROBLASTS; GENE THERAPY; MALE; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; PROSTHESES AND IMPLANTS; RATS; RATS, WISTAR; RETROVIRIDAE; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 50349092984     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-248-3_20     Document Type: Article

References (67)

1. Lane, J. M., Tomin, E. and Bostrom, M. P. (1999) Biosynthetic bone grafting. Clin. Orthop. Relat. Res. S107-S117.
2. Bostrom, M. P., Saleh, K. J. and Einhorn, T. A. (1999) Osteoinductive growth factors in preclinical fracture and long bone defects models. Orthop. Clin. North Am. 30, 647-658.
3. Bucholz, R. W. (2002) Nonallograft osteoconductive bone graft substitutes. Clin. Orthop. Relat. Res. 44-52.
4. Finkemeier, C. G. (2002) Bone-grafting and bone-graft substitutes. J. Bone Joint Surg. Am. 84-A, 454-464.
5. Khan, S. N., Tomin, E. and Lane, J. M. (2000) Clinical applications of bone graft substitutes. Orthop. Clin. North Am. 31, 389-398.
6. Perry, C. R. (1999) Bone repair techniques, bone graft, and bone graft substitutes. Clin. Orthop. Relat. Res. 71-86.
7. Vaccaro, A. R. (2002) The role of the osteoconductive scaffold in synthetic bone graft. Orthopedics 25, s571-s578.
8. Friedlaender, G. E., Perry, C. R., Cole, J. D., Cook, S. D., Cierny, G., Muschler, G. F., Zych, G. A., Calhoun, J. H., LaForte, A. J. and Yin, S. (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg. Am. 83-A Suppl 1, S151-S158.
9. Geesink, R. G., Hoefnagels, N. H. and Bulstra, S. K. (1999) Osteogenic activity of OP-I bone morphogenetic protein (BMP-7) in a human fibular defect. J. Bone Joint Surg. Br. 81, 710-718.
10. Johnson, E. E., Urist, M. R. and Finerman, G. A. (1988) Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin. Orthop. Relat. Res. 257-265.
11. Wozney, J. M. (2002) Overview of bone morphogenetic proteins. Spine 27, S2-S8.
12. Uludag, H., Gao, T., Porter, T. J., Friess, W. and Wozney, J. M. (2001) Delivery systems for BMPs: factors contributing to protein retention at an application site. J. Bone Joint. Surg. Am. 83-A Suppl 1, S128-S135.
13. Bruder, S. P. and Fox, B. S. (1999) Tissue engineering of bone. Cell based strategies. Clin. Orthop. Relat. Res. S68-S83.
14. Calvert, J. W., Weiss, L. E. and Sundine, M. J. (2003) New frontiers in bone tissue engineering. Clin. Plast. Surg. 30, 641-648, x.
15. Cowan, C. M., Soo, C., Ting, K. and Wu, B. (2005) Evolving concepts in bone tissue engineering. Curr. Top. Dev. Biol. 66, 239-285.
16. Mistry, A. S. and Mikos, A. G. (2005) Tissue engineering strategies for bone regeneration. Adv. Biochem. Eng. Biotechnol. 94, 1-22.
17. Arinzeh, T. L., Peter, S. J., Archambault, M. P., van den, B. C., Gordon, S., Kraus, K., Smith, A. and Kadiyala, S. (2003) Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J. Bone Joint Surg. Am. 85-A, 1927-1935.
18. Bruder, S. P., Fink, D. J. and Caplan, A. I. (1994) Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J. Cell Biochem. 56, 283-294.
19. Mauney, J. R., Volloch, V. and Kaplan, D. L. (2005) Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng. 11, 787-802.
20. Kahn, A., Gibbons, R., Perkins, S. and Gazit, D. (1995) Age-related bone loss. A hypothesis and initial assessment in mice. Clin. Orthop. Relat. Res. 69-75.
21. Ohgushi, H., Goldberg, V. M. and Caplan, A. I. (1989) Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop. Scand. 60, 334-339.
22. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S. M., Mukhachev, V., Lavroukov, A., Kon, E. and Marcacci, M. (2001) Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 344, 385-386.
23. Wang, J. C., Kanim, L. E., Yoo, S., Campbell, P. A., Berk, A. J. and Lieberman, J. R. (2003) Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J. Bone Joint Surg. Am. 85-A, 905-911.
24. Lieberman, J. R., Le, L. Q., Wu, L., Finerman, G. A., Berk, A., Witte, O. N. and Stevenson, S. (1998) Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J. Orthop. Res. 16, 330-339.
25. Lieberman, J. R., Daluiski, A., Stevenson, S., Wu, L., McAllister, P., Lee, Y. P., Kabo, J. M., Finerman, G. A., Berk, A. J. and Witte, O. N. (1999) The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. Am. 81, 905-917.
26. Blum, J. S., Barry, M. A., Mikos, A. G. and Jansen, J. A. (2003) In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Hum. Gene Ther. 14, 1689-1701.
27. Park, J., Ries, J., Gelse, K., Kloss, F., von der, M. K., Wiltfang, J., Neukam, F. W. and Schneider, H. (2003) Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther. 10, 1089-1098.
28. Chang, S. C., Chuang, H. L., Chen, Y. R., Chen, J. K., Chung, H. Y., Lu, Y. L., Lin, H. Y., Tai, C. L. and Lou, J. (2003) Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration. Gene Ther. 10, 2013-2019.
29. Gysin, R., Wergedal, J. E., Sheng, M. H., Kasukawa, Y., Miyakoshi, N., Chen, S. T., Peng, H., Lau, K. H., Mohan, S. and Baylink, D. J. (2002) Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats. Gene Ther. 9, 991-999.
30. Bruder, S. P. and Fox, B. S. (1999) Tissue engineering of bone. Cell based strategies. Clin. Orthop. Relat. Res. S68-S83.
31. Haynesworth, S. E., Goshima, J., Goldberg, V. M. and Caplan, A. I. (1992) Characterization of cells with osteogenic potential from human marrow. Bone 13, 81-88.
32. Bruder, S. P., Jaiswal, N. and Haynesworth, S. E. (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell Biochem. 64, 278-294.
33. Quarto, R., Thomas, D. and Liang, C. T. (1995) Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int. 56, 123-129.
34. Harada, S. and Rodan, G. A. (2003) Control of osteoblast function and regulation of bone mass. Nature 423, 349-355.
35. Ryoo, H. M., Lee, M. H. and Kim, Y. J. (2006) Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 366, 51-57.
36. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G. (1997) Osf2/Cbfal: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
37. Ishida, Y. and Heersche, J. N. M. (1998) Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J. Bone Miner. Res. 13, 1822-1826.
38. Canalis, E. and Delany, A. M. (2002) Mechanisms of glucocorticoid action in bone. Ann. N Y Acad. Sci. 966, 73-81.
39. Bellows, C. G., Aubin, J. E. and Heersche, J. N. M. (1987) Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaría cells - in vitro. Endocrinology 121, 1985-1992.
40. Cheng, S. L., Yang, J. W., Rifas, L., Zhang, S. F. and Avioli, L. V. (1994) Differentiation of human bone-marrow osteogenic stromal cells in vitro - induction of the osteoblast phenotype by dexamethasone. Endocrinology 134, 277-286.
41. Brann, D. W., Hendry, L. B. and Mahesh, V. B. (1995) Emerging diversities in the mechanism of action of steroid-hormones. J. Steroid Biochem. Mol. Biol. 52, 113-133.
42. Boyan, B. D. and Schwartz, Z. (2004) Rapid vitamin D-dependent PKC signaling shares features with estrogen-dependent PKC signaling in cartilage and bone. Steroids 69, 591-597.
43. Chen, T. L., Cone, C. M. and Feldman, D. (1983) Glucocorticoid modulation of cell-proliferation in cultured osteoblast-like bone-cells - differences between rat and mouse. Endocrinology 112, 1739-1745.
44. Rickard, D. J., Sullivan, T. A., Shenker, B. J., Leboy, P. S. and Kazhdan, I. (1994) Induction of rapid osteoblast differentiation in rat bone-marrow stromal cell-cultures by dexamethasone and Bmp-2. Dev. Biol. 161, 218-228.
45. Prince, M., Banerjee, C., Javed, A., Green, J., Lian, J. B., Stein, G. S., Bodine, P. V. and Komm, B. S. (2001) Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J. Cell Biochem. 80, 424-440.
46. Viereck, V., Siggelkow, H., Tauber, S., Raddatz, D., Schutze, N. and Hufner, M. (2002) Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts. J. Cell Biochem. 86, 348-356.
47. Pei, W., Yoshimine, Y. and Heersche, J. N. M. (2003) Identification of dexamethasone-dependent osteoprogenitors in cell populations derived from adult human female bone. Calcif. Tissue Int. 72, 124-134.
48. Shui, C. X., Spelsberg, T. C., Riggs, B. L. and Khosla, S. (2003) Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J. Bone Miner. Res. 18, 213-221.
49. Franceschi, R. T., Yang, S., Rutherford, R. B., Krebsbach, P. H., Zhao, M. and Wang, D. (2004) Gene therapy approaches for bone regeneration. Cells Tissues Organs 176, 95-108.
50. Rutherford, R. B., Moalli, M., Franceschi, R. T., Wang, D., Gu, K. and Krebsbach, P. H. (2002) Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng. 8, 441-452.
51. Zhao, M., Zhao, Z., Koh, J. T., Jin, T. and Franceschi, R. T. (2005) Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J. Cell Biochem. 95, 1-16.
52. Yang, S., Wei, D., Wang, D., Phimphilai, M., Krebsbach, P. H. and Franceschi, R. T. (2003) In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J. Bone Miner. Res. 18, 705-715.
53. Hirata, K., Tsukazaki, T., Kadowaki, A., Furukawa, K., Shibata, Y., Moriishi, T., Okubo, Y., Bessho, K., Komori, T., Mizuno, A. et al. (2003) Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2. Bone 32, 502-512.
54. Krebsbach, P. H., Gu, K., Franceschi, R. T. and Rutherford, R. B. (2000) Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum. Gene Ther. 11, 1201-1210.
55. Byers, B. A., Pavlath, G. K., Murphy, T. J., Karsenty, G. and Garcia, A. J. (2002) Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfa1. J. Bone Miner. Res. 17, 1931-1944.
56. Byers, B. A. and Garcia, A. J. (2004) Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells. Tissue Eng. 10, 1623-1632.
57. Byers, B. A., Guldberg, R. E. and Garcia, A. J. (2004) Synergy between genetic and tissue engineering: Runx2 overexpression and in vitro construct development enhance in vivo mineralization. Tissue Eng. 10, 1757-1766.
58. Gersbach, C. A., Byers, B. A., Pavlath, G. K. and Garcia, A. J. (2004) Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp. Cell Res. 300, 406-417.
59. Phillips, J. E., Gersbach, C. A., Wojtowicz, A. M. and Garcia, A. J. (2006) Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J. Cell Sci. 119, 581-591.
60. Phillips, J. E., Guldberg, R. E. and Garcia, A. J. (2007). Dermal fibroblasts genetically modified to express Runx2/Cbfa1 are a mineralizing cell source for bone tissue engineering applications. 13, 2029-2040.
61. Phillips, J. E., Guldberg, R. E. and Garcia, A. J. (2006). Mineralization capacity of Runx2/Cbfa1-expressing fibroblasts is scaffold-dependent. Biomaterials. 27, 5535-5545.
62. Gersbach, C. A., Byers, B. A., Pavlath, G. K., Guldberg, R. E. and Garcia, A. J. (2004) Runx2/Cbfa1-genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro. Biotechnol. Bioeng. 88, 369-378.
63. Sauer, G. R. and Wuthier, R. E. (1988) Fourier transform infrared characterization of mineral phases formed during induction of mineralization by collagenasereleased matrix vesicles in vitro. J. Biol. Chem. 263, 13718-13724.
64. Boskey, A. L., Guidon, P., Doty, S. B., Stiner, D., Leboy, P. and Binderman, I. (1996) The mechanism of beta-glycerophosphate action in mineralizing chick limbbud mesenchymal cell cultures. J. Bone Miner. Res. 11, 1694-1702.
65. Boyan, B. D., Schwartz, Z. and Boskey, A. L. (2000) The importance of mineral in bone and mineral research. Bone 27, 341-342.
66. Bonewald, L. F., Harris, S. E., Rosser, J., Dallas, M. R., Dallas, S. L., Camacho, N. P., Boyan, B. and Boskey, A. (2003) von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif. Tissue Int. 72, 537-547.
67. Bonewald, L. F., Dallas, S., Qiao, M., Camacho, N. P., Boyan, B. and Boskey, A. (1996) Comparison of mineralized matrix of fetal rat calvarial cells and MC-3T3-E1 osteoblast-like cells by Fourier transform infrared spectroscopy (FT-IR). J. Bone Miner. Res. 11, S333.